Cures Within Reach’s mission is to leverage the speed, safety and cost-effectiveness of testing already approved therapies for new indications that improve patient quality and length of life, serving philanthropic and/or commercial uses – driving more treatments to more patients more quickly.

Our focus: funding the projects that, when successful, will catalyze follow-on funding and/or further trials and publications.  We focus on impacting patients with unmet medical needs, whether a repurposed treatment may have philanthropic value or commercial value.

Congrats to David Fajgenbaum, MD, MBA, MSc and Incyte with their 2022 Patient Impact Awards! Read more here.

Read about the 9 new DEI clinical trials we recently selected!

Catch up on all our activities in 2021 with our Annual Report:

CWR Annual Report 2021 coverimage

Read about our 2022 growth plans: 

in Diversity, Equity & Inclusion

in Pediatrics

and for Veterans/Military


Thanks to those who golfed or donated for our annual Golf Fundraiser in June – more details about our record year here!



The global healthcare community is working together in unprecedented ways to treat patients and learn from each other. There are many opportunities underway using already approved drugs in clinical trials to treat COVID19 patients, providing evidence-based medicine to clinicians.

Read more about the many clinical repurposing trials:


Resources for Repurposing in COVID19

clinical research for unsolved diseases

Diseases Researched

repurposing research grants funding

Repurposing Projects Funded


Institutions Funded


Success Stories


Startups with CWR Investments


Companies Commercializing CWR Projects


Millions of Dollars in Project Funding

repurposing-research-initiated -follow-on-funding supporting clinical research

Millions of Dollars in Follow-on Funding Leveraged